Degnan Chris sold URGN
October 8, 2025 · Form 4 insider transaction
Degnan Chris sold 2,203 shares of UroGen Pharma Ltd. at $16.85 per share, a transaction worth $37.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,203
Price
$16.85
Total value
$37.1K
InsiderDegnan Chris
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateOctober 8, 2025
Filing dateOctober 9, 2025
Shares owned after2,280
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.